BioNxt Solutions Inc. (CVE:BNXT)

PRESS RELEASE

published on 11/20/2025 at 09:05, 2 months 14 days ago

BioNxt Secures Final Patent Grant from the Eurasian Patent Organization for Sublingual Cladribine Platform
BioNxt Solutions Inc. receives Eurasian Patent No. 051510 for sublingual anticancer drug delivery system, a key milestone in global IP strategy. Expansion to EU and US markets in progress

BioNxt Solutions Inc. Sublingual Delivery Eurasian Patent Pharmaceutical Markets Global IP Strategy
BRIEF

published on 11/04/2025 at 09:10, 3 months ago

BioNxt Receives European Patent Notification for Cladribine Thin-Film

Multiple Sclerosis Oral Therapies Cladribine European Patent BioNxt
BRIEF

published on 11/04/2025 at 09:10, 3 months ago

BioNxt reçoit une notification de brevet européen pour son film mince de cladribine

Sclérose En Plaques Thérapies Orales Cladribine Brevet Européen BioNxt
PRESS RELEASE

published on 11/04/2025 at 09:05, 3 months ago

BioNxt Reports "Intention to Grant" Patent Notification from the European Patent Office for Its Oral Cladribine Sublingual Thin-Film as the Multiple Sclerosis Market Shifts Toward Patient-Friendly Therapies
BioNxt Solutions Inc. receives 'Intention to Grant' notification from European Patent Office for sublingual cladribine thin-film formulation for MS treatment, securing extensive IP protection across Europe and Eurasia

BioNxt Solutions Inc. European Patent Office MS Treatment Sublingual Thin-Film Global Patent Coverage
BRIEF

published on 10/30/2025 at 08:10, 3 months 5 days ago

BioNxt Solutions Inc. fait progresser un brevet pour l'administration de médicaments anticancéreux

Sclérose En Plaques Solutions BioNxt Administration De Médicaments Brevet Eurasien Stratégie En Matière De Brevets
BRIEF

published on 10/30/2025 at 08:10, 3 months 5 days ago

BioNxt Solutions Inc. Advances Patent for Cancer Drug Delivery

Multiple Sclerosis Drug Delivery BioNxt Solutions Eurasian Patent Patent Strategy
PRESS RELEASE

published on 10/30/2025 at 08:05, 3 months 5 days ago

BioNxt Reports "Readiness to Grant" Patent Notification from the Eurasian Patent Organization
BioNxt Solutions Inc. receives "Readiness to Grant" notification from EAPO for comprehensive patent application on sublingual delivery of anticancer drugs for autoimmune neurodegenerative diseases, including lead product BNT23001 for MS treatment. Patent protection strengthens commercialization strategy

BioNxt Solutions Inc. Patent Application Sublingual Drug Delivery Anticancer Drugs EAPO
BRIEF

published on 10/21/2025 at 09:10, 3 months 14 days ago

BioNxt Initiates Sublingual Cladribine Study for MS Treatment Optimization

Multiple Sclerosis Bioavailability Drug Delivery Bioequivalence Study Sublingual Cladribine
BRIEF

published on 10/21/2025 at 09:10, 3 months 14 days ago

BioNxt lance une étude sur la cladribine sublinguale pour optimiser le traitement de la sclérose en plaques

Sclérose En Plaques Biodisponibilité Étude De Bioéquivalence Administration De Médicaments Cladribine Sublinguale
PRESS RELEASE

published on 10/21/2025 at 09:05, 3 months 14 days ago

BioNxt Launches 15-day Sublingual Cladribine Dosing Optimization Study in Preparation for Human Bioequivalence Study
BioNxt Solutions Inc. announces a large-mass animal bioequivalence study for sublingual Cladribine formulation, targeting multiple sclerosis treatment, to optimize dosage parameters for upcoming human study

BioNxt Solutions Inc. Multiple Sclerosis Treatment Bioequivalence Study Drug Delivery Technologies Sublingual Cladribine Formulation

Published on 02/04/2026 at 18:00, 2 hours 31 minutes ago

Lithium South AGSM Update
Published on 02/04/2026 at 16:15, 4 hours 16 minutes ago

Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Published on 02/04/2026 at 15:45, 4 hours 46 minutes ago

Patriot.Tv's Jd Rucker Explains Billie Eilish's Comments on ICE, Offers ICE Commentary as Exhibit A of Celebrity Sound Bite Politics
Published on 02/04/2026 at 15:00, 5 hours 31 minutes ago

Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale
Published on 02/04/2026 at 14:30, 6 hours 1 minute ago

Datametrex Expands Business In Data Centres

View all ACCESSWIRE

Published on 02/04/2026 at 20:00, 31 minutes ago

Belgium's Ingmar De Vos elected to Executive Board of International Olympic Committee
Published on 02/04/2026 at 18:55, 1 hour 36 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/04/2026 at 18:40, 1 hour 51 minutes ago

Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology
Published on 02/04/2026 at 18:34, 1 hour 57 minutes ago

E-PANGO: Composition du capital au 31 janvier 2026
Published on 02/04/2026 at 18:14, 2 hours 17 minutes ago

Issue of Equity

View all EQS

Published on 02/04/2026 at 18:04, 2 hours 27 minutes ago

Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 2 hours 27 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 2 hours 46 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 2 hours 46 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 02/04/2026 at 17:45, 2 hours 46 minutes ago

Janvier 2026

View all LES ECHOS COMFI WIRE

News